If you’ve been looking for a safe, non-surgical method to kick-start your weight loss and regain a healthy lifestyle, take a look at the Spatz3 Adjustable Balloon - an effective, reversible and less costly alternative to weight loss surgery for individuals who are overweight or obese.
How does it work?
The Spatz3 Adjustable Balloon is a medical grade, saline-filled gastric balloon that rests in the stomach cavity and decreases appetite by occupying approximately a third of the stomach volume. In addition, with the gastric balloon in place, the stomach empties more slowly, keeping you feeling full longer.
The Spatz3 Adjustable Balloon is inserted during an outpatient procedure that takes about 20 minutes and is performed under sedation. No incisions or hospitalization required. Youll be home within a few hours.
The Spatz3 Adjustable Balloon is a tool to aid weight loss and will yield the best result when used in conjunction with diet, exercise and a behavior modification program.
The amount of weight you lose will depend on how closely you follow your diet and adopt long-term lifestyle changes. Average weight losses of 16 kg after 6 months and 25 kg after 12 months are reported with the Spatz3 Adjustable Balloon. Depending on your initial weight and your motivation, significantly greater weight losses have been achieved.
Can it work for me?
Over the past 30 years, more than 100,000 people have lost an average of 10-30 kg of weight with the assistance of gastric balloons. Your individual motivation and willingness to comply with dietary changes and behavior. modification are important factors in your ultimate success with the Spatz3 Adjustable Balloon.
Patients with certain medical conditions cannot be approved for Spatz3 Adjustable Balloon implantation. The decision to undergo gastric balloon therapy must be made in consultation with a qualified physician.
How much you weigh has a great deal to do with your health. Diseases that are known to stem from obesity...
How is the Spatz3 balloon superior to other gastric balloons?
Over 100,000 individuals have chosen gastric balloons as an alternative to weight loss surgery, diets, pills and other weight loss programs that haven't yielded the results they desire...The Spatz3 Adjustable Balloon has two main advantages over the typical gastric balloon.
The Spatz3 Adjustable Balloon is safe enough to be used for a full year. Thats twice the length of time for which other gastric balloons are approved.
As your body gets used to any gastric balloon, its effectiveness diminishes. This generally happens 3 to 4 months after implantation. The Spatz3 Adjustable Balloon is uniquely adjustable, which means that your physician can boost your weight loss when necessary with a simple, outpatient adjustment of the balloons volume.
Can I afford it?
This is a decision only you can make. Your physician will discuss the cost of full treatment, including the procedures, screening tests, follow up visits, nutritional and behavior modification consultations.
As you are making your decision, remember to factor in the potential healthcare cost savings you will realize when your overall health improves as a result of weight loss. Studies in the US have shown the average annual cost of obesity to be over $15,000 per year.
Exciting News! Spatz Balloon Procedure now available in Costa Rica
Spatz FGIA to exhibit at Digestive Disease Week (DDW) in in San Diego CA, USA, May 22-24, 2016.
Please visit our booth number 422.
One Year After Government Approval, The Spatz3 Adjustable Gastric Balloon Finds Success In Mexico And Along The U.S. Border
COFEPRIS, the Mexican Health authority, approved Spatz3 Adjustable Gastric Balloon
Feb 17, 2016, 09:57 ET from Spatz FGIA, Inc.
Spatz Medical now offers an affordable medical tourism solution for US citizens who have been waiting for a chance to try the Spatz3 adjustable gastric balloon.
Spatz FGIA poster presentation “FIRST REPORTS OF THE NEW SPATZ 3 ADJUSTABLE BALLOON SYSTEM”, at the 2014 Canadian Digestive Diseases Week (CDDW) and Annual CASL Winter Meeting at Poster Session II (Monday, February 10, 17h00-18h30 in the Ballroom and Salon B). The abstract will be published in the Canadian Journal of Gastroenterology, CDDW issue.
“Adjustable Intragastric Balloons: A 12-Month Pilot Trial in Endoscopic Weight Loss Management.”
Machytka E, Klvana P, Kornbluth A, Peikin S, Mathus-Vliegen LE, Gostout C, Lopez-Nava G, Shikora S, Brooks J.
Obes Surg. 2011 May 8. [Epub ahead of print]
“The Big Picture: Hoping to Avoid the Knife”